IDEXX Laboratories (IDXX) Fell Due to Weakening of Clinical Visits by Patients
Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 2,662,855 | $1,100,930,771 | -1% | 4.69% |
| 2. | Alyeska Investment Group Anand Parekh | 378,318 | $156,411,794 | 0.58% | |
| 3. | Millennium Management Israel Englander | 256,228 | $105,934,904 | +65% | 0.05% |
| 4. | D E Shaw D. E. Shaw | 212,136 | $87,705,508 | +69% | 0.06% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 207,114 | $85,629,215 | +633% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | Director | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | Director | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | Director | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | Director | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | Director | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $462.53 | 9,986 | Officer | 8,176 | 2025-02-10 | Filing | |
| $465.95 | 3,000 | Director | 3,061 | 2025-02-07 | Filing | |
| $420.44 | 344 | Director | 905 | 2024-11-27 | Filing | |
| $469.37 | 500 | Director | 0 | 2024-09-06 | Filing | |
| $540.80 | 200 | Director | 161 | 2024-05-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,709,510 | $4,014,299,815 | 0.06% | |
| 2. | 8,472,562 | $3,502,896,286 | 0.07% | |
| 3. | 3,637,560 | $1,503,886,376 | 0.05% | |
| 4. | 2,297,271 | $948,278,610 | 0.07% | |
| 5. | 2,005,522 | $829,163,016 | 2.14% |
News See All
Here’s Why IDEXX Laboratories (IDXX) Declined in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S.
Jim Cramer On 9 Stocks That Are Rallying Despite Tariff Worries
On Monday, Jim Cramer, the host of Mad Money, told viewers that they should not be too surprised by President Donald Trump's decision to impose steep tariff hikes, a move Trump had promised during his...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
Why IDXX Is Soaring Today
Pet healthcare firm Idexx (IDXX) is jumping 10% after delivering better-than-expected fourth-quarter financial results.
Jim Cramer Looked At These 7 Stocks Recently
On Mad Money, Jim Cramer recently delved into the impact of previous President Joe Biden’s policies on the stock market, raising a question that has been on the minds of many executives: Did the market...
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Business Model Mastery. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.
Jim Cramer Recently Discussed These 7 Stocks
Jim Cramer, host of Mad Money, recently addressed how investors can sometimes lose sight of the broader market perspective.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Douglas Ott. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.